Advertisement - Members don't see this ad
Schering-Plough's Drug Sugammadex Rejected by U.S.
> Aug. 1 (Bloomberg) -- Schering-Plough Corp.'s drug sugammadex for the
> reversal of general anesthesia was rejected by U.S. regulators.
>
> Schering-Plough, based in Kenilworth, New Jersey, received a
> ``not-approvable'' letter from the Food and Drug Administration, the
> drugmaker said today in a statement. Schering-Plough said it would
> work with the agency to ``address the issues, which are primarily
> related to hypersensitivity/allergic reactions.''
Anyone heard otherwise?
.
> Aug. 1 (Bloomberg) -- Schering-Plough Corp.'s drug sugammadex for the
> reversal of general anesthesia was rejected by U.S. regulators.
>
> Schering-Plough, based in Kenilworth, New Jersey, received a
> ``not-approvable'' letter from the Food and Drug Administration, the
> drugmaker said today in a statement. Schering-Plough said it would
> work with the agency to ``address the issues, which are primarily
> related to hypersensitivity/allergic reactions.''
Anyone heard otherwise?
.
